Cemaliye  B. Akyerli B. Akyerli

Dr. Cemaliye B. Akyerli B. Akyerli

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2005 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
ZÖZeynep Özbalkan
Zeynep Özbalkan
SBSevgi Baǧışlar
Sevgi Baǧışlar
SKSedat Kiraz
Sedat Kiraz
CACemaliye B. Akyerli B. Akyerli
Cemaliye B. Akyerli B. Akyerli
HÖHüseyin T. E. Özer
Hüseyin T. E. Özer
TÖTayfun Özçelik
Tayfun Özçelik
Objective: Scleroderma (SSc) is an autoimmune disease of unknown etiology. The disease is 3–8 times more frequent in women than in men. The role of X chromosome inactivation (XCI) in the predisposition of women to autoimmunity has been questioned. Until now this has not been illustrated experimentally. This study was undertaken to test the hypothesis that disturbances in XCI mosaicism may be involved in the pathogenesis of the disease in female patients with SSc.Methods: Seventy female SSc patients and 160 female controls were analyzed for the androgen receptor locus by theHpaII/polymerase chain reaction assay to assess XCI patterns in DNA extracted from peripheral blood cells. Furthermore, skin biopsy samples were obtained from 5 patients whose blood revealed an extremely skewed pattern of XCI, and the analysis repeated. Since microchimerism in SSc was reported, Y chromosome sequences were investigated in all samples.Results: Skewed XCI was observed in DNA from peripheral blood cells in 35 of 55 informative patients (64%), as compared with 10 of 124 informative controls (8%) (P< 0.0001). Extreme skewing was present in 27 of the patient group (49%), as compared with only 3 of the controls (2.4%) (P< 0.0001). However, XCI was random in all skin biopsy samples. The potential contribution of microchimerism to the random XCI pattern is highly unlikely based on the medical histories of the patients.Conclusion: Skewed XCI mosaicism may play a significant role in the pathogenesis of SSc.

5 April 2006 in European Journal of Human Genetics
Verified
Journal Article
Closed access
TOTayfun Ozcelik
Tayfun Ozcelik
EUElif Uz
Elif Uz
CACemaliye B. Akyerli B. Akyerli
Cemaliye B. Akyerli B. Akyerli
SBSevgi Bagislar
Sevgi Bagislar
CMChigdem A Mustafa
Chigdem A Mustafa
SGSevim Gullu
Sevim Gullu

1 January 2002 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
MTMeral Topçu
Meral Topçu
CACemaliye B. Akyerli B. Akyerli
Cemaliye B. Akyerli B. Akyerli
ASAyça Sayı
Ayça Sayı
Gokce A TorunerGokce A Toruner
Gokce A Toruner
SKSüha R Koçoğlu
Süha R Koçoğlu
TÖTayfun Özçelik
Tayfun Özçelik
Rett syndrome is a severe neurodevelopmental disorder that arises from mutations in the X-linked MECP2 gene. It is almost exclusively seen in girls due to the predominant occurrence of the mutations on the paternal X-chromosome, and also the early postnatal lethal effect of the disease causing mutations in hemizygous boys. We identified a boy with features of classic Rett syndrome who is mosaic for the truncating MECP2 mutation R270X. Chromosome analysis showed normal karyotype. These results indicate that a MECP2 mutation associated with Rett syndrome in females could lead to a similar phenotype in males as a result of somatic mosaicism.

1 October 2001 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
Gokce A TorunerGokce A Toruner
Gokce A Toruner
CACemaliye B. Akyerli B. Akyerli
Cemaliye B. Akyerli B. Akyerli
AUAhmet Uçar
Ahmet Uçar
TATuncay Akı
Tuncay Akı
NANecmettin Atsu
Necmettin Atsu
TÖTayfun Özçelik
Tayfun Özçelik

21 February 2023 in Frontiers in Genetics
Verified
Journal Article
Open access
HKHilal Keskin Karakoyun
Hilal Keskin Karakoyun
ŞYŞirin K. Yüksel
Şirin K. Yüksel
IAIlayda Amanoglu
Ilayda Amanoglu
LNLara Naserikhojasteh
Lara Naserikhojasteh
AYAhmet Yeşilyurt
Ahmet Yeşilyurt
CACemaliye B. Akyerli B. Akyerli
Cemaliye B. Akyerli B. Akyerli
Identifying pathogenic missense variants in hereditary cancer is critical to the efforts of patient surveillance and risk-reduction strategies. For this purpose, many different gene panels consisting of different number and/or set of genes are available and we are particularly interested in a panel of 26 genes with a varying degree of hereditary cancer risk consisting of ABRAXAS1, ATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53, and XRCC2. In this study, we have compiled a collection of the missense variations reported in any of these 26 genes. More than a thousand missense variants were collected from ClinVar and the targeted screen of a breast cancer cohort of 355 patients which contributed to this set with 160 novel missense variations. We analyzed the impact of the missense variations on protein stability by five different predictors including both sequence- (SAAF2EC and MUpro) and structure-based (Maestro, mCSM, CUPSAT) predictors. For the structure-based tools, we have utilized the AlphaFold (AF2) protein structures which comprise the first structural analysis of this hereditary cancer proteins. Our results agreed with the recent benchmarks that computed the power of stability predictors in discriminating the pathogenic variants. Overall, we reported a low-to-medium-level performance for the stability predictors in discriminating pathogenic variants, except MUpro which had an AUROC of 0.534 (95% CI [0.499–0.570]). The AUROC values ranged between 0.614–0.719 for the total set and 0.596–0.682 for the set with high AF2 confidence regions. Furthermore, our findings revealed that the confidence score for a given variant in the AF2 structure could alone predict pathogenicity more robustly than any of the tested stability predictors with an AUROC of 0.852. Altogether, this study represents the first structural analysis of the 26 hereditary cancer genes underscoring 1) the thermodynamic stability predicted from AF2 structures as a moderate and 2) the confidence score of AF2 as a strong descriptor for variant pathogenicity.

15 March 2008 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
YBYusuf Bayraktar
Yusuf Bayraktar
OHOzgur Harmanci
Ozgur Harmanci
YBYahya Büyükasik
Yahya Büyükasik
ASAli Ibrahim Shorbagi
Ali Ibrahim Shorbagi
ASAysegul Hasegeli Sungur
Aysegul Hasegeli Sungur
FBFerhun Balkanci
Ferhun Balkanci